RegCell
regcellbio.com
Biotechnology
RegCell focuses on restoring self-tolerance to the immune system, aiming to transform the treatment of autoimmune diseases. The company develops innovative therapies to address the underlying causes, offering new hope for patients suffering from these conditions.
Founded
2018
Total Funding
Tens of millions
Total Rounds
3
First Raise
Mar 18, 2025
Latest Raise
Sep 15, 2026
Get notified when RegCell and companies like it raise
New funding rounds in your inbox every week · No noise, all Signal.
This company may have changed its name or domain. Shared founders detected on: alessatherapeutics.com
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
Showing 1 of 3 rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/15/2026 | |||
2 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
RegCell · Never miss the next round
Who's raising next?
New funding rounds in your inbox every week · Free